Zerbo, O.

About

Publications While At HealthPartners

selected publications

Journal Article

18 years - VISION and IVY Networks, September 2024-January 2025.

MMWR: Morbidity and Mortality Weekly Report. 2025

2 Total citations

2 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Vaccination during pregnancy in the Vaccine Safety Datalink, 2002-2022.

Pediatric Infectious Disease Journal. 2025

COVID-19 vaccination in the first trimester and major structural birth defects among live births.

JAMA pediatrics. 2024

11 Total citations

11 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 states, June 2021-March 2023.

Clinical Infectious Diseases. 2024

16 Total citations

16 Recent citations

14 Field Citation Ratio

4.49 Relative Citation Ratio

Effectiveness of the original monovalent and bivalent COVID-19 vaccines against COVID-19-associated emergency department and urgent care encounters in pregnant persons who were not immunocompromised: VISION Network, June 2022-August 2023.

Open forum infectious diseases. 2024

Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study.

JMIR public health and surveillance. 2024

3 Total citations

3 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States.

Clinical Infectious Diseases. 2024

1 Total citation

1 Recent citation

n/a Field Citation Ratio

n/a Relative Citation Ratio

Influenza vaccine effectiveness against influenza A-associated emergency department, urgent care, and hospitalization encounters among US adults, 2022-2023.

Journal of Infectious Diseases. 2024

11 Total citations

11 Recent citations

7.84 Field Citation Ratio

2.47 Relative Citation Ratio

Obstetric complications and birth outcomes after antenatal coronavirus disease 2019 (COVID-19) vaccination.

Obstetrics and Gynecology. 2024

4 Total citations

4 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection.

Nature communications. 2024

14 Total citations

14 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.

Lancet (London, England). 2024

17 Total citations

17 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Safety of the seasonal influenza vaccine in 2 successive pregnancies.

JAMA network open. 2024

2 Total citations

2 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Vaccine effectiveness against pediatric influenza-A-associated urgent care, emergency department, and hospital encounters during the 2022-2023 season: VISION Network.

Clinical Infectious Diseases. 2024

7 Total citations

7 Recent citations

4.99 Field Citation Ratio

n/a Relative Citation Ratio

Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy.

Vaccine. 2023

2 Total citations

2 Recent citations

2.27 Field Citation Ratio

0.39 Relative Citation Ratio

Effectiveness of BNT162b2 COVID-19 vaccination in children and adolescents.

Pediatrics. 2023

10 Total citations

10 Recent citations

9.1 Field Citation Ratio

0.79 Relative Citation Ratio

Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: an observational study of real-world data across 10 US states from August-December 2021.

Vaccine. 2023

7 Total citations

7 Recent citations

6.37 Field Citation Ratio

0.76 Relative Citation Ratio

Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods.

JAMA network open. 2023

66 Total citations

65 Recent citations

60 Field Citation Ratio

6.8 Relative Citation Ratio

Influenza vaccination among pregnant people before and during the coronavirus disease 2019 (COVID-19) pandemic.

Obstetrics and Gynecology. 2023

1 Total citation

1 Recent citation

0.91 Field Citation Ratio

0.22 Relative Citation Ratio

Medically attended acute adverse events in pregnant people after coronavirus disease 2019 (COVID-19) booster vaccination.

Obstetrics and Gynecology. 2023

6 Total citations

6 Recent citations

6.81 Field Citation Ratio

1.04 Relative Citation Ratio

Protection of two and three mRNA vaccine doses against severe outcomes among adults hospitalized with COVID-19--VISION Network, August 2021 to March 2022.

Journal of Infectious Diseases. 2023

12 Total citations

12 Recent citations

6.52 Field Citation Ratio

1.29 Relative Citation Ratio

Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness.

Clinical Infectious Diseases. 2023

12 Total citations

12 Recent citations

10 Field Citation Ratio

1.88 Relative Citation Ratio

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink.

Vaccine. 2023

8 Total citations

8 Recent citations

7.28 Field Citation Ratio

1.55 Relative Citation Ratio

Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network.

Journal of Infectious Diseases. 2023

16 Total citations

16 Recent citations

11 Field Citation Ratio

1.79 Relative Citation Ratio

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.

Vaccine. 2022

11 Total citations

10 Recent citations

5.82 Field Citation Ratio

1.02 Relative Citation Ratio

Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults - VISION Network, nine states, September-November 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

93 Total citations

91 Recent citations

50 Field Citation Ratio

3.92 Relative Citation Ratio

Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated - VISION Network, 10 states, December 2021-June 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

114

114 Total citations

74 Recent citations

61 Field Citation Ratio

6.16 Relative Citation Ratio

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

179

179 Total citations

100 Recent citations

97 Field Citation Ratio

10 Relative Citation Ratio

Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 Omicron predominance - VISION Network, 10 states, December 2021-August 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

71 Total citations

68 Recent citations

38 Field Citation Ratio

3.69 Relative Citation Ratio

Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

412

412 Total citations

160 Recent citations

113 Field Citation Ratio

25 Relative Citation Ratio

Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen (Johnson & Johnson)) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults - VISION Network, 10 states, December 2021-March 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

51 Total citations

30 Recent citations

14 Field Citation Ratio

2.69 Relative Citation Ratio

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-nine states, January-September 2021.

American Journal of Transplantation. 2022

12 Total citations

7 Recent citations

6.52 Field Citation Ratio

0.52 Relative Citation Ratio

Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States.

JAMA network open. 2022

51 Total citations

49 Recent citations

27 Field Citation Ratio

3.63 Relative Citation Ratio

Evaluation of acute adverse events after Covid-19 vaccination during pregnancy.

New England Journal of Medicine. 2022

42 Total citations

37 Recent citations

28 Field Citation Ratio

2.72 Relative Citation Ratio

Health care utilization in the 6 months following SARS-CoV-2 infection.

JAMA network open. 2022

41 Total citations

40 Recent citations

21 Field Citation Ratio

3.69 Relative Citation Ratio

Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines.

Pediatrics. 2022

6 Total citations

6 Recent citations

3.18 Field Citation Ratio

0.59 Relative Citation Ratio

Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021.

MMWR: Morbidity and Mortality Weekly Report. 2022

182

182 Total citations

111 Recent citations

119 Field Citation Ratio

16 Relative Citation Ratio

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.

Vaccine. 2022

53 Total citations

40 Recent citations

28 Field Citation Ratio

2.61 Relative Citation Ratio

Safety of COVID-19 vaccination in United States children ages 5 to 11 years.

Pediatrics. 2022

47 Total citations

32 Recent citations

24 Field Citation Ratio

2.7 Relative Citation Ratio

Safety of live-attenuated vaccines in children exposed to biologic response modifiers in utero.

Pediatrics. 2022

4 Total citations

4 Recent citations

n/a Field Citation Ratio

0.16 Relative Citation Ratio

Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

429

429 Total citations

204 Recent citations

233 Field Citation Ratio

26 Relative Citation Ratio

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study.

BMJ (Clinical research ed.). 2022

158

158 Total citations

155 Recent citations

83 Field Citation Ratio

10 Relative Citation Ratio

COVID-19 vaccination coverage among insured persons aged ≥16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

41 Total citations

20 Recent citations

10 Field Citation Ratio

2.13 Relative Citation Ratio

COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

181

181 Total citations

87 Recent citations

87 Field Citation Ratio

13 Relative Citation Ratio

Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

176

176 Total citations

80 Recent citations

68 Field Citation Ratio

7.5 Relative Citation Ratio

Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings.

New England Journal of Medicine. 2021

430

430 Total citations

187 Recent citations

158 Field Citation Ratio

18 Relative Citation Ratio

Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

100

100 Total citations

34 Recent citations

38 Field Citation Ratio

3.03 Relative Citation Ratio

Surveillance for adverse events after COVID-19 mRNA vaccination.

JAMA. 2021

540

540 Total citations

245 Recent citations

191 Field Citation Ratio

32 Relative Citation Ratio

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination.

Therapeutic advances in drug safety. 2021

34 Total citations

24 Recent citations

16 Field Citation Ratio

2.62 Relative Citation Ratio

Order of live and inactivated vaccines and risk of non-vaccine-targeted infections in US children 11-23 months of age.

Pediatric Infectious Disease Journal. 2020

3 Total citations

0 Recent citations

0.53 Field Citation Ratio

0.14 Relative Citation Ratio

Risk for subdeltoid bursitis after influenza vaccination: a population-based cohort study.

Annals of Internal Medicine. 2020

24 Total citations

6 Recent citations

7.08 Field Citation Ratio

1.58 Relative Citation Ratio

Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age.

JAMA. 2018

46 Total citations

10 Recent citations

6.53 Field Citation Ratio

1.53 Relative Citation Ratio

Contact

full name

O. Zerbo

Quick Info

Publications

Collaboration

Co-author network

Map of science

O. Zerbo All authors

About

Publications While At HealthPartners

selected publications

Journal Article

Contact

full name

Quick Info

Publications Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Publications